Developments in Abortion, Autonomy, and Access:
This week’s Digest covers where reproductive health access is on the ballot this November, the Food and Drug Administration’s court filing establishing a Spring 2027 timeline to complete its mifepristone safety review, and a novel civil suit in Texas invoking House Bill 7’s medication transport prohibitions against anti-abortion activists who conducted a pill-ordering stunt. We also discuss the accelerating wave of hospital maternity ward closures across the country, new reporting detailing systemic insurer violations of the Affordable Care Act’s contraceptive coverage mandates, a University of Michigan study linking post-Dobbs state abortion bans to higher health insurance premiums for women, and the appointment of White House Press Secretary Katie Zacharia amid scrutiny over her past leadership ties to an anti-abortion organization. As always, please read on to the end for the news that you need to know.
Want access to a detailed analysis of the abortion law in every U.S. state and territory? Please view our free Policy Resource Hub for Reproductive Health, an exclusive legal database where we update the state of the law every single day - so you’re always up to speed.
If you’d rather not receive the bi-weekly Reproductive Health Digest but still want to get other L4GG emails, you can opt out of just this newsletter here.
Legislation & Litigation:
Overview
The Food and Drug Administration notified a federal court that its ongoing administrative review of mifepristone safety data will extend into early next year, deferring any potential federal regulatory changes until spring 2027;
A Texas resident filed a civil lawsuit invoking state abortion pill transport prohibitions against anti-abortion activists who ordered abortion medication online during a public demonstration within state borders; and
Abortion is on the ballot in multiple states this November.
FDA Formally Establishes Spring 2027 Timeline to Complete Re-evaluation of Mifepristone Safety and Telehealth Rules:
On October 7th, the DOJ filed an official status report in federal district court stating that the Food and Drug Administration (FDA) review of mifepristone will extend into early next year. In the court-ordered update, the DOJ confirmed the study, which will reportedly evaluate the side effects of mifepristone across roughly 100,000 patients, will conclude in mid-December 2026. A final report is expected in March 2027. The review, commissioned last year by HHS Secretary Robert F. Kennedy Jr. following pressure from conservative groups, utilizes statistical data mining across electronic health records to re-evaluate the agency’s 2021 and 2023 determinations that in-person dispensing of mifepristone is not medically necessary.
The update came in a federal lawsuit brought by Louisiana alleging that mail-order distribution of abortion pills undermines its state abortion ban. However, existing Supreme Court orders keep current mail and telehealth access intact nationwide while litigation and agency reviews continue. By establishing a March 2027 completion date, it appears that the agency is unlikely to take any independent action to significantly modify the regulation of mifepristone prior to the spring.
Novel Civil Lawsuit Invokes Texas Medication Transport Ban Against Anti-Abortion Activists:
A recent lawsuit filed in Harris County District Court targets four activists affiliated with Students for Life of America under Texas House Bill 7. Known as the Woman and Child Protection Act, House Bill 7 prohibits providing, delivering, or transporting abortion-inducing drugs to or from anyone in Texas. It employs a broad civil enforcement framework that allows any private citizen, regardless of their connection to the alleged violation, to bring a lawsuit seeking statutory damages against defendants.
The complaint argues that defendants violated state law when they attempted to order medication abortion online while standing outside Space Center Houston as part of a media demonstration intended to highlight the ease of accessing pills. The filing references social media posts documenting the incident, alongside reporting by Mother Jones journalists who observed the ordering process.
Represented by Amplify Legal, the legal arm of Abortion in America, the plaintiff alleges that state abortion bans forced her to carry two unplanned pregnancies to term at severe financial cost, leaving her unable to complete college or maintain employment. The suit seeks $459,782 in damages – the estimated average cost of raising two children to age 18 in Texas. Under HB 7, the plaintiff would be entitled to receive $10,000 of any recovery herself, and the remaining damages would go to a charity of her choosing. She has indicated that she would donate the funds to Jane's Due Process, a nonprofit dedicated to helping young people access abortion and birth control.
Attorneys for the plaintiff argue that while state law exempts pregnant individuals seeking abortion care from civil liability, non-pregnant activists ordering medication inside state borders fall directly within the statutory prohibitions against transporting and facilitating abortion medication. The lawsuit is a novel application of Texas private civil enforcement mechanisms, turning medication abortion restrictions drafted with the support of anti-abortion advocates against anti-abortion activists themselves.
State Ballot Measures and Federal Litigation Strategy Highlight Pre-Election Landscape:
Reproductive health access is on the ballot in four states this November. In Nevada and Virginia, where most abortions are currently legal, proposed constitutional amendments would cement those protections. Nevada’s Question 6 passed with nearly 65% approval in 2024 - it requires a second consecutive passage to take effect. If successful, the ballot question would add a right to pre-viability abortion care to the state constitution. Similarly in Virginia, Question 1, referred by the General Assembly, asks voters to guarantee a constitutional right to comprehensive reproductive healthcare, including contraception, fertility care, and abortion prior to the third trimester.
In Idaho, voters will consider Proposition 1, a citizen-initiated state statute designed to create an independent right to reproductive freedom and privacy, establish protections for procedures before fetal viability, and shield healthcare providers from criminal, civil, and professional liability. Importantly, Idaho’s measure would only create statutory protections - it would not amend the state constitution. Conversely, Missouri voters face Amendment 3, a legislatively referred constitutional proposal that seeks to repeal the voter-approved 2024 reproductive freedom amendment and constitutionally enshrine strict gestational limits, parental consent mandates, and restrictions on gender-affirming care for minors.
Trend and Policy Watch:
Overview
Impending federal Medicaid cuts are driving a wave of hospital maternity ward closures across the country, worsening rural maternal healthcare shortages;
A new report reveals that insurance companies continue to violate Affordable Care Act rules by denying no-cost birth control coverage;
A new study finds that state abortion bans following the 2022 Dobbs decision are associated with a 5.4% increase in out-of-pocket health insurance premiums for women; and
President Trump named former media commentator Katie Zacharia as White House Press Secretary, drawing scrutiny over her recent tenure on the advisory board of an anti-abortion organization.
Federal Medicaid Funding Restrictions Accelerate Nationwide Closures of Hospital Maternity Units:
A new analysis by healthcare advocacy group Protect Our Care reports that 52 hospital maternity wards have permanently closed since the 2025 passage of HR 1, also known as the One Big Beautiful Bill Act. An additional eight facilities have announced plans to close in the upcoming year. HR 1 has forced healthcare institutions to restructure by reducing federal Medicaid funding, imposing restrictions on state funding, introducing mandatory work requirements, and increasing burdensome eligibility re-certifications. Taken together, these changes place significant financial and logistical strain on safety-net institutions that rely on Medicaid to cover roughly 40% of births nationwide.
Facility administrators at impacted regional institutions, including Central Southside Community Hospital in Virginia and St. Mary’s Sacred Heart Hospital in rural Georgia, cited federal policy shifts and projected operating losses as primary drivers behind terminating obstetrical services. Erin Jones, from March of Dimes, highlights that the trend threatens to create expansive maternity care deserts, identifying 31 rural hospitals whose potential closures would leave 96 counties without localized labor and delivery services.
National Women’s Law Center Report Highlights Ongoing Insurer Noncompliance With Federal Contraceptive Coverage Mandates:
The National Women’s Law Center released a report examining ongoing implementation failures in the Affordable Care Act’s requirement that health plans provide preventative care without cost-sharing. Drawing from intake data collected through its CoverHer assistance hotline, the analysis found that insurers frequently exclude entire categories of birth control methods, deny coverage for integral clinical services such as office visits or surgical anesthesia, and impose improper medical management protocols like age restrictions or mandatory “try and fail” requirements. The report notes that individuals who experienced unlawful coverage denials incurred an average out-of-pocket cost of $2,097.19 annually between 2022 and 2025, while also highlighting a sharp increase in requests for permanent contraception following the Supreme Court decision overturning federal abortion protections.
University of Michigan Study Associates Post-Dobbs State Abortion Bans With Increased Insurance Costs for Women:
Researchers at the University of Michigan’s Institute for Social Research analyzed data from the Current Population Survey to better understand how abortion bans impact out-of-pocket expenditures for women aged 18 to 44. The study, authored by Joelle Abramowitz and Olga Aristova, looked at data from 2018 to 2024 and found that residing in states with abortion bans is associated with a 5.4% rise in annual out-of-pocket health insurance premium spending for women. This increase appears to be driven by higher birth rates, increased care complications, and elevated maternal risks that prompt insurers to pass costs onto beneficiaries. The economic impact was disproportionately concentrated among communities of color, with annual out-of-pocket premium spending rising by 12.8% for Black women and 13.7% percent for Latine women. The paper notes that while non-premium out-of-pocket costs and men’s insurance spending showed no statistically significant change, women in affected states experienced a 2.6% increase in private health insurance coverage and bore higher proportions of employer-sponsored plan premiums.
White House Appoints Press Secretary with Ties to Abortion Abolitionist Movement:
The President appointed political commentator Katie Zacharia as the 37th White House Press Secretary, following the departure of Karoline Leavitt. Zacharia, who held her inaugural press briefing on October 13th, served until early 2026 on the advisory board of The White Rose Resistance, an extremist anti-abortion organization that advocates for treating abortion as capital murder and prosecuting both providers and patients under criminal homicide statutes. Zacharia has drawn past criticism for public statements comparing medication abortion to chemical agents used in Nazi extermination camps. The appointment underscores growing links between the federal administration and the self-described “abortion abolitionist” movement, which seeks the complete criminalization of abortion and full implementation of fetal personhood principles.
